News | Breast Imaging | April 15, 2026

New viewer, optimized for QT Imaging’s breast imaging technology, simplifies correlation of breast imaging across modalities and over time, and supports future integration of AI/ML-based tools.

breast imaging, women's healthcare,

April 15, 2026 — QT Imaging Holdings, Inc. has launched its QTI Imaging-Olea Viewer, developed in collaboration with Olea Medical, a provider of advanced imaging software solutions.The QT Imaging-Olea Viewer provides a unified platform for viewing multiple breast imaging modalities, enabling clinicians to efficiently correlate findings across imaging sources and monitor patients longitudinally. By reducing reliance on multiple software viewers, the system streamlines workflow, enhances clinical efficiency, and supports more informed patient management over time.

“Integrating quantitative, radiation-free QTscan data with mammography, digital breast tomosynthesis, MRI and ultrasound in a single intuitive platform improves interpretive efficiency, strengthens diagnostic confidence, and supports a more comprehensive multimodality approach to breast evaluation,” said Dr. Bilal Malik, chief medical officer of QT Imaging.

QT Imaging’s Breast Acoustic CT system leverages advanced ultrasound tomography to deliver true 3D volumetric breast imaging without ionizing radiation or painful compression. Designed to provide quantitative, reproducible imaging data, the technology offers particular clinical value in women with dense breast tissue. Powered by Olea Medical’s industry leading visualization framework, the QT Imaging-Olea Viewer enables comprehensive analysis of QT Imaging datasets through advanced 3D rendering, quantitative assessment, and integrated AI/ML capabilities, including future automated lesion segmentation and computer-aided detection applications.

“Our collaboration with QT Imaging shows how advanced software and imaging innovation can seamlessly come together to benefit clinicians and patients alike,” said Faycal Djeridane, founder and chief executive officer of Olea Medical. “By integrating QT Imaging’s quantitative biomarkers into our advanced imaging platform, we’re enabling a data-rich, cohesive viewing experience that enhances diagnostic efficiency.”

The QT-Viewer was developed under a QT Imaging and Olea Medical collaboration that was announced in January 2026.

The QT Imaging-Olea Viewer will be available for demonstration at the SBI Breast Imaging Symposium, April 16-19, in Seattle, Washington. 

For more information on QT Imaging, please visit www.qtimaging.com.


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Breast Imaging

Oct. 9, 2026 – A new study in the Journal of the American College of Radiology, published by Elsevier, has found that ...

Time October 15, 2026
arrow
News | Breast Imaging

Oct. 6, 2026 — The American College of Radiology (ACR) has recognized Mercy Medical Center’s Tyanna O’Brien Center for ...

Time October 09, 2026
arrow
Subscribe Now